Aveanna Healthcare Holdings (AVAH) Cost of Revenue (2020 - 2026)
Aveanna Healthcare Holdings' Cost of Revenue history spans 7 years, with the latest figure at $449.2 million for Q1 2026.
- For Q1 2026, Cost of Revenue rose 29.02% year-over-year to $449.2 million; the TTM value through Jan 2026 reached $1.6 billion, up 16.83%, while the annual FY2026 figure was $1.6 billion, 16.83% up from the prior year.
- Cost of Revenue reached $449.2 million in Q1 2026 per AVAH's latest filing, up from $419.1 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $449.2 million in Q1 2026 to a low of $297.9 million in Q3 2022.
- Average Cost of Revenue over 5 years is $349.3 million, with a median of $344.8 million recorded in 2024.
- Peak YoY movement for Cost of Revenue: fell 17.7% in 2022, then rose 29.02% in 2026.
- A 5-year view of Cost of Revenue shows it stood at $322.4 million in 2022, then rose by 2.49% to $330.4 million in 2023, then rose by 5.37% to $348.2 million in 2024, then grew by 20.38% to $419.1 million in 2025, then grew by 7.17% to $449.2 million in 2026.
- Per Business Quant, the three most recent readings for AVAH's Cost of Revenue are $449.2 million (Q1 2026), $419.1 million (Q3 2025), and $378.8 million (Q2 2025).